Ian Taylor
Fortuna: 1 M $ al 31/05/2026
Fortuna: 1 M $ al 31/05/2026
En la actualidad, Ian Taylor es director científico de Arvinas, Inc. En el pasado ocupó el cargo de Director Senior de Oncología Translacional en Pfizer Inc. y Vicepresidente de Biología del Cáncer en Bayer HealthCare. El Dr. Taylor se licenció en el Bowdoin College y se graduó en la Universidad de Harvard.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ARVINAS, INC. 0,22 % | 31/03/2026 | 138.876 ( 0,22 % ) | 1 M $ | 31/05/2026 |
| Empresas | Cargo | Fin |
|---|---|---|
| ARVINAS, INC. | Director Técnico/Científico/I+D | 06/06/2025 |
| PFIZER INC. | Corporate Officer/Principal | 01/05/2016 |
Bayer HealthCare
Bayer HealthCare Medical/Nursing ServicesHealth Services Provides medical care, and animal health care services | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bowdoin College
Bowdoin College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bayer HealthCare
Bayer HealthCare Medical/Nursing ServicesHealth Services Provides medical care, and animal health care services | Health Services |
Arvinas, Inc.
Arvinas, Inc. BiotechnologyHealth Technology Engages in discovery, development and commercialization of therapies to degrade disease-causing proteins | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.